Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Esther Rajavelu Insider Profile
4 Followers
Esther Rajavelu, CFO at Fulcrum Therapeutics, holds ― shares in Fulcrum Therapeutics (Ticker: FULC), holds 379.27K shares in Spero Therapeutics (Ticker: SPRO). Most recently, Esther Rajavelu ― shares of Fulcrum Therapeutics on ― for an estimated value of ―.
Esther Rajavelu has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Esther Rajavelu holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Esther Rajavelu
Esther Rajavelu's Trading History
Fulcrum Therapeutics
―
CFO
―
―
Spero Therapeutics
Nov 12, 2024
CFO & CBO
Informative Sell
53.01K
$451.33K
List of latest transactions for each holding click on a transaction to see Esther Rajavelu's performance on stock
You May Also Like
Esther Rajavelu insider profile FAQ
What is the percentage of profitable transactions made by Esther Rajavelu?
The percentage of profitable transactions made by Esther Rajavelu is ―.
What is the average return per transaction made by Esther Rajavelu?
The average return per transaction made by Esther Rajavelu is ―.
What stocks does Esther Rajavelu hold?
Esther Rajavelu holds: FULC, SPRO stocks.
What was Esther Rajavelu’s latest transaction?
Esther Rajavelu latest transaction was an Uninformative Buy of ―.
What was Esther Rajavelu's most profitable transaction?
Esther Rajavelu’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Esther Rajavelu's role in Fulcrum Therapeutics?
Esther Rajavelu's role in Fulcrum Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.